Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Valérie Chabaud"'
Autor:
Marie-Laure Vuillaume, Nancy Uhrhammer, Véronique Vidal, Valérie Sylvain Vidal, Valérie Chabaud, Beline Jesson, Fabrice Kwiatkowski, Yves-Jean Bignon
Publikováno v:
Cancer Informatics, Vol 7, Pp 41-56 (2009)
Mutations in two major genes, BRCA1 and BRCA2, account for up to 30% of families with hereditary breast cancer. Unfortunately, in most families there is little to indicate which gene should be targeted first for mutation screening, which is labor int
Externí odkaz:
https://doaj.org/article/3ac49b0a27af4df88478ffb88582fd06
Autor:
Marie-Laure Vuillaume, Nancy Uhrhammer, Véronique Vidal, Valérie Sylvain Vidal, Valérie Chabaud, Beline Jesson, Fabrice Kwiatkowski, Yves-Jean Bignon
Publikováno v:
Cancer Informatics, Vol 7 (2009)
Mutations in two major genes, BRCA1 and BRCA2 , account for up to 30% of families with hereditary breast cancer. Unfortunately, in most families there is little to indicate which gene should be targeted first for mutation screening, which is labor in
Externí odkaz:
https://doaj.org/article/85b8b38ae6154573accb30fe53e6b9ab
Autor:
Henri Vié, Régine Vivien, Philippe Lemarre, Valérie Chabaud, Soraya Saiagh, Béline Jesson, Patrice Chevallier, Thierry Guillaume, Ulrich Jarry, Catherine Godon, Béatrice Clémenceau
Publikováno v:
Cytotherapy
Cytotherapy, Elsevier, 2018, 20 (3), pp.436-452. ⟨10.1016/j.jcyt.2017.12.002⟩
Cytotherapy, Elsevier, 2018, 20 (3), pp.436-452. 〈10.1016/j.jcyt.2017.12.002〉
Cytotherapy, 2018, 20 (3), pp.436-452. ⟨10.1016/j.jcyt.2017.12.002⟩
Cytotherapy, Elsevier, 2018, 20 (3), pp.436-452. ⟨10.1016/j.jcyt.2017.12.002⟩
Cytotherapy, Elsevier, 2018, 20 (3), pp.436-452. 〈10.1016/j.jcyt.2017.12.002〉
Cytotherapy, 2018, 20 (3), pp.436-452. ⟨10.1016/j.jcyt.2017.12.002⟩
International audience; Background aims. To produce an anti-leukemic effect after hematopoietic stem cell transplantation we have long considered the theoretical possibility of using banks of HLA-DP specific T-cell clones transduced with a suicide ge